Futura Medical: Broker repeats 'buy' recommendation and 102p price target
Liberum was heartened by both the regulatory and commercial progress being made by the developer of erectile dysfunction gel MED3000.
Company
Futura Medical PLC
LON:FUM
Futura Medical specialises in the development and global commercialisation of innovative sexual health products, including lead product Eroxon®. The company's core strength lies in its research, development and commercialisation of topically delivered gel formulations in sexual health products.
305 stories · page 6 of 16
Futura Medical says 'multiple' potential out-licensing parties' interested in erectile dysfunction gel
The company delivered a comprehensive update on its progress
Futura Medical adds consumer healthcare products veteran to board
Jeff Needham was at Perrigo, the US-based manufacturer and marketer of consumer healthcare products, for 36 years
Futura Medical well-funded and on-track
The results for the six months revealed the company was sitting on £12.76mln as at June 30
Futura Medical agrees third commercial deal for fast-acting erectile gel
It has teamed up with a Swiss company called Labatec Pharma, which will oversee the regulatory sign-off of the product in the Gulf Co-operation Council region as well as Jordan, Lebanon and Iraq
Futura Medical says countdown to regulatory sign-off of erectile dysfunction gel begins
It has hosted the first patient visit as part of the company's FM71 confirmatory study
Futura Medical: More deals will follow after LatAm agreement, says City broker
“Futura is talking to many more potential partners as it works to build the global commercialisation landscape, and we expect more licensing agreements to be signed in the coming months,” said Liberum in a note to clients
Futura Medical inks deal that will take its erectile dysfunction gel to Brazil and Mexico
It has partnered with the speciality pharma group, m8 Pharmaceuticals
Futura Medical makes headway with US drug regulator as it looks to sell erectile dysfunction gel over the counter
It has been given sign-off for a simple human factors study by the Food & Drug Administration
Archive
Proactive news headlines: Guild Esports, Ferro Alloy Resources, City Pub Group, NFT Investments...
A glance at some of the day's highlights from the Proactive Investors newswire
Futura Medical in talks with potential licensing partners; FDA interactions on track
Chairman John Clarke will tell the firm's AGM: “The team is laser-focused on preparation and execution of the confirmatory clinical study and the non-clinical study to finalise an OTC [over-the-counter] label for the regulatory submission f
Futura Medical raises funds for a small confirmatory clinical study for MED3000
MED3000 is Futura's topical gel formulation that is a breakthrough treatment for erectile dysfunction through a unique evaporative mode of action
Futura Medical better placed for commercial deals with EU approval, says Liberum
"Approval removes the last hurdle to signing meaningful commercial agreements"
Futura Medical confirms EU CE mark for MED3000 has been granted
Futura's fast-acting topical gel formulation MED3000 is the first clinically proven, pan-European topical treatment for adult men with erectile dysfunction available over the counter
How Futura Medical turned MED3000 into a near-billion pound opportunity
The erectile dysfunction gel will be commercialised in Europe this year after the pharma company navigated unexpected twists and turns along the way
Futura Medical well-positioned to announce more positive news on MED3000 after year of milestones
The pharma company is eyeing a global rollout after receiving the CE mark in Europe
Futura Medical soars (again) after US Food & Drug Administration agreement
The main purpose of the trial is to ensure that the efficacy of the erectile dysfunction gel does not wear off after more than three months of use.
Archive
Futura Medical hails "huge milestone"; Destiny Pharma rises after it receives US support
It was a good week for two relative tiddlers in the pharmaceutical sector
Proactive news headlines: Futura Medical, Caerus Mineral Resources, Trident Royalties, Alien Metals...
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Scottish Mortgage Investment Trust lower after joint portfolio manager jumps ship
A look at Friday's major share movers in the London Stock Exchange